Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Intimate Rose vs TeleClinic

Intimate Rose
Graded #126

Higher grade

vs+8.5
TeleClinic
Graded #313

Lower grade

The verdict

Intimate Rose takes it — 69.3/100 to 60.8/100.

Intimate Rose grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Intimate Rose is an established US women's and pelvic-health brand that has added an online weight-management program offering compounded GLP-1 medication.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIntimate Rose +22
66
44
Dose & formulationIntimate Rose +32
96
64
Clinical oversightTeleClinic +4
76
80
Labs & monitoringEven
52
52
FulfillmentTeleClinic +33
64
97
Contract termsIntimate Rose +17
37
20
Intimate Rose · left barTeleClinic · right bar

The numbers

MetricIntimate RoseTeleClinic
WeighScore69.3/10060.8/100
GradeCC
Scorecard rank#126#313
Semaglutide$169/mo (all doses, compounded)$199/mo (compounded)
Tirzepatide$169/mo (all doses, compounded)$299/mo (compounded)
CoverageCoverage not published47 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Intimate Rose

Graded #126 · C

Strengths

  • Transparent pricing from 169 dollars per month shown upfront, not gated behind intake
  • Medication and free delivery included, HSA and FSA eligible, no contract
  • Backed by an established women's-health brand using the OpenLoop provider network

Where it loses points

  • State availability not published
  • Oral compounded GLP-1 only; no injectable option shown
  • No specific compounding pharmacy named (network fulfillment via OpenLoop)
TeleClinic

Graded #313 · C

Strengths

  • Names its pharmacy partner — Rush Pharmacy, a licensed 503A compounder — which many compounded-GLP-1 telehealths won't disclose
  • LegitScript certified with flat, published monthly pricing, free shipping, and no insurance required
  • Broad access: 47 states with US-licensed physicians and transparent cash-pay pricing

Where it loses points

  • Compounded semaglutide and tirzepatide only — no brand-name GLP-1 (Wegovy or Zepbound) option
  • Headline $139/$219 rates are first-quarter intro prices billed quarterly; ongoing month-to-month is $199/$299
  • Not available in California, South Carolina, or New Jersey

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard